Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Canetti G. Present aspects of bacterial resistance in tuberculosis. Am Rev Respir Dis. 1965 Nov;92(5):687–703. doi: 10.1164/arrd.1965.92.5.687. [DOI] [PubMed] [Google Scholar]
- Dickinson J. M., Mitchison D. A. Bactericidal activity in vitro and in the guinea-pig of isoniazid, rifampicin and ethambutol. Tubercle. 1976 Dec;57(4):251–258. doi: 10.1016/s0041-3879(76)80002-5. [DOI] [PubMed] [Google Scholar]
- Dickinson J. M., Mitchison D. A. Experimental models to explain the high sterilizing activity of rifampin in the chemotherapy of tuberculosis. Am Rev Respir Dis. 1981 Apr;123(4 Pt 1):367–371. doi: 10.1164/arrd.1981.123.4.367. [DOI] [PubMed] [Google Scholar]
- Dutt A. K., Moers D., Stead W. W. Short-course chemotherapy for extrapulmonary tuberculosis. Nine years' experience. Ann Intern Med. 1986 Jan;104(1):7–12. doi: 10.7326/0003-4819-104-1-7. [DOI] [PubMed] [Google Scholar]
- Dutt A. K., Moers D., Stead W. W. Undesirable side effects of isoniazid and rifampin in largely twice-weekly short-course chemotherapy for tuberculosis. Am Rev Respir Dis. 1983 Sep;128(3):419–424. doi: 10.1164/arrd.1983.128.3.419. [DOI] [PubMed] [Google Scholar]
- Dutt A. K., Stead W. W. Present chemotherapy for tuberculosis. J Infect Dis. 1982 Nov;146(5):698–704. doi: 10.1093/infdis/146.5.698. [DOI] [PubMed] [Google Scholar]
- Fox W., Mitchison D. A. Short-course chemotherapy for pulmonary tuberculosis. Am Rev Respir Dis. 1975 Mar;111(3):325–353. doi: 10.1164/arrd.1975.111.3.325. [DOI] [PubMed] [Google Scholar]
- Fox W. The chemotherapy of pulmonary tuberculosis: a review. Chest. 1979 Dec;76(6 Suppl):785–796. doi: 10.1378/chest.76.6_supplement.785. [DOI] [PubMed] [Google Scholar]
- Grosset J. Bacteriologic basis of short-course chemotherapy for tuberculosis. Clin Chest Med. 1980 May;1(2):231–241. [PubMed] [Google Scholar]
- Jindani A., Aber V. R., Edwards E. A., Mitchison D. A. The early bactericidal activity of drugs in patients with pulmonary tuberculosis. Am Rev Respir Dis. 1980 Jun;121(6):939–949. doi: 10.1164/arrd.1980.121.6.939. [DOI] [PubMed] [Google Scholar]
- MACKANESS G. B. The intracellular activation of pyrazinamide and nicotinamide. Am Rev Tuberc. 1956 Nov;74(5):718–728. doi: 10.1164/artpd.1956.74.5.718. [DOI] [PubMed] [Google Scholar]
- MCCUNE R. M., Jr, MCDERMOTT W., TOMPSETT R. The fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. II. The conversion of tuberculous infection to the latent state by the administration of pyrazinamide and a companion drug. J Exp Med. 1956 Nov 1;104(5):763–802. doi: 10.1084/jem.104.5.763. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McDERMOTT W., TOMPSETT R. Activation of pyrazinamide and nicotinamide in acidic environments in vitro. Am Rev Tuberc. 1954 Oct;70(4):748–754. doi: 10.1164/art.1954.70.4.748. [DOI] [PubMed] [Google Scholar]
- Mitchison D. A., Nunn A. J. Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis. Am Rev Respir Dis. 1986 Mar;133(3):423–430. doi: 10.1164/arrd.1986.133.3.423. [DOI] [PubMed] [Google Scholar]
- Mitchison D. A. The action of antituberculosis drugs in short-course chemotherapy. Tubercle. 1985 Sep;66(3):219–225. doi: 10.1016/0041-3879(85)90040-6. [DOI] [PubMed] [Google Scholar]
- Mitchison D. A. Treatment of tuberculosis. The Mitchell lecture 1979. J R Coll Physicians Lond. 1980 Apr;14(2):91-5, 98-9. [PMC free article] [PubMed] [Google Scholar]
- Snider D. E., Jr, Cohn D. L., Davidson P. T., Hershfield E. S., Smith M. H., Sutton F. D., Jr Standard therapy for tuberculosis 1985. Chest. 1985 Feb;87(2 Suppl):117S–124S. doi: 10.1378/chest.87.2.117s. [DOI] [PubMed] [Google Scholar]